NasdaqCM:AHGHealthcare
Is Akso Health Group's (AHG) Early BCI Bet Quietly Redefining Its Long-Term Innovation Narrative?
In April 2026, Akso Health Group announced it had begun a next-generation Brain-Computer Interface research and development program, building foundational infrastructure to pursue ultra-high-resolution neural sensing, real-time AI neural decoding, and advanced interface design, with related patent applications pending.
The company emphasized that it has not yet started human clinical trials, made any regulatory submissions, or generated revenue from BCI activities, underscoring the...